Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia
sabinurce / Pixabay

Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia

According to a story from Market Screener, the biopharmaceutical company Orchard Therapeutics recently announced that the results of a recent clinical trial testing the company' investigational product OTL-300 were encouraging.…

Continue Reading Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia
Parliamentary Debate Highlights Continued Controversy and Misinformation Surrounding CFS/ME
marusya21111999 / Pixabay

Parliamentary Debate Highlights Continued Controversy and Misinformation Surrounding CFS/ME

According to a story from The ME Association, a recent debate that came to the floor of the UK parliament highlights the misinformation and deficits in care surrounding children with…

Continue Reading Parliamentary Debate Highlights Continued Controversy and Misinformation Surrounding CFS/ME
Company Releases Early Data and Plans to Boost Dose in Duchenne Muscular Dystrophy Trial
PhotoLizM / Pixabay

Company Releases Early Data and Plans to Boost Dose in Duchenne Muscular Dystrophy Trial

According to a story from pm360online.com, the life sciences company Solid Biosciences has released some preliminary findings from its Phase 1/2 clinical trial of SGT-001. This investigational product is in…

Continue Reading Company Releases Early Data and Plans to Boost Dose in Duchenne Muscular Dystrophy Trial
Company Plans Extension Study for Phase 3 Trial of Amyotrophic Lateral Sclerosis Drug
source: pixabay.com

Company Plans Extension Study for Phase 3 Trial of Amyotrophic Lateral Sclerosis Drug

According to a story from pm360online.com, the Orion Corporation, a pharmaceutical company based in Finland, has recently announced that it plans to continue its Phase 3 trial of levosimendan as…

Continue Reading Company Plans Extension Study for Phase 3 Trial of Amyotrophic Lateral Sclerosis Drug
Company Earns Orphan Drug Designation for Autoimmune Hepatitis From the FDA
www_slon_pics / Pixabay

Company Earns Orphan Drug Designation for Autoimmune Hepatitis From the FDA

According to a story from finanznachrichten.de, the Swedish drug company Calliditas Therapeutics has recently announced that the US Food and Drug Administration (FDA) has given one of the company's experimental drugs…

Continue Reading Company Earns Orphan Drug Designation for Autoimmune Hepatitis From the FDA

Potential Gene Therapy for Late Infantile Batten Disease Earns Rare Pediatric Disease Designation

According to a story from BioSpace, the biotechnology company REGENXBIO, Inc. recently announced that its experimental gene therapy candidate called RGX-181 has been granted Rare Pediatric Disease designation from the…

Continue Reading Potential Gene Therapy for Late Infantile Batten Disease Earns Rare Pediatric Disease Designation
This Website Hopes to Help Women With Inflammatory Bowel Disease Have Healthy Pregnancies
FotografieLink / Pixabay

This Website Hopes to Help Women With Inflammatory Bowel Disease Have Healthy Pregnancies

According to a story from Reuters, a new website developed by the American Gastroenterological Association is meant to help women that have inflammatory bowel disease have safe and healthy pregnancies.…

Continue Reading This Website Hopes to Help Women With Inflammatory Bowel Disease Have Healthy Pregnancies
Why is it Difficult to Diagnose Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?
cocoparisienne / Pixabay

Why is it Difficult to Diagnose Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?

According to a story from WebMD, the rare nervous system disorder chronic inflammatory demyelinating polyneuropathy is notorious for being difficult to diagnose. Many rare diseases can be challenging to identify.…

Continue Reading Why is it Difficult to Diagnose Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?